Business Context and Reporting Period
Company: LifeMD, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 17, 2025
Reporting Period: The filing announces financial results for the three and nine months ended September 30, 2025.
Key Financial Metrics
The provided text is a cover page and index for the 8-K filing. It references a press release (Exhibit 99.1) containing the actual financial data but does not include the specific numbers within this document.
- Revenue, Profit, Cash Flow, Margins: Not provided in the filing text; contained in the referenced press release.
- Debt and Liquidity: Not provided in the filing text; contained in the referenced press release.
Material Changes
The filing text does not provide specific comparative data or material changes versus prior periods. It only indicates that results for the three and nine months ended September 30, 2025, have been announced.
Guidance, Outlook, and Risks
Management Commentary: The filing states that a press release was issued on November 17, 2025, detailing the results. Specific commentary, guidance, or outlook is not included in the text provided.
Risks and Contingencies: No specific risks or contingencies are detailed in this excerpt.
Unusual Items: None identified in the provided text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated November 17, 2025) for actual revenue, net income, and cash flow figures.
- Verify the specific performance metrics for the three and nine months ended September 30, 2025, against prior year periods.
- Check for any forward-looking statements or updated guidance included in the full press release.
- Confirm the status of the 8.875% Series A Cumulative Perpetual Preferred Stock (LFMDP) mentioned in the securities section.